查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医学图像分析软件市场：2019-2029 年全球市场规模、份额、趋势分析、机会和预测报告
市场调查报告书
商品编码
1301831

医学图像分析软件市场：2019-2029 年全球市场规模、份额、趋势分析、机会和预测报告

Medical Image Analysis Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Software ; By Modality ; By Imaging ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，全球医学图像分析软件市场将超过 56.2 亿美元

全球医学图像分析软件市场受到超声成像设备（尤其是用于快速诊断疑难杂症）以及技术先进的医学成像设备（如多模态成像平台和3D成像）的日益使用的推动，并由于招聘的增加而蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计，2022 年全球医学图像分析软件市场价值将达到 33 亿美元。 BlueWeave预测，在2023-2029年预测期内，全球医学图像分析软件市场规模将以7.80%的年复合成长率增长，到2029年将达到56.2亿美元。特别是，越来越多地使用超声成像设备来快速诊断疑难杂症，这被认为推动了对医学图像分析软件的需求。除了越来越多地采用多模态成像平台和 3D 成像等技术先进的产品外，使用这些系统的高分辨率成像、易用性和灵活性等优势也正在帮助增加对老年人口的增加导致慢性病的数量增加。此类疾病的日益流行可能会增加诊断成像技术的使用并加强医学图像分析软件的市场。

该报告的详细分析提供了有关全球医学图像分析软件市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告提供了全球医学图像分析软件市场的最新技术趋势和行业见解，以帮助决策者做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争动态。

目录

第1章研究框架

第2章执行摘要

第3章全球医学图像分析软件市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长动力
      • 慢性病患病率增加
      • 将人工智能融入医学图像分析软件
      • 对效率和效益的需求不断增长
    • 抑制因素
      • 预算限制
      • 人们对软件合规性和安全性的担忧日益增加
    • 机会
      • 技术进步
    • 任务
      • 缺乏熟练的专业人员
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第4章全球医学图像分析软件市场概述

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
      • 集成软件
      • 独立软件
    • 按方式
      • 断层扫描
      • CT检查
      • 磁共振成像
      • 正电子发射断层扫描
      • 单光子发射断层扫描
      • 超声成像
      • 射线照相成像
      • 联合模式
    • 通过成像
      • 二维成像
      • 3D成像
      • 4D成像
    • 按用途
      • 骨科
      • 牙科
      • 神经病学
      • 心脏病学
      • 肿瘤学
      • 妇产科
      • 乳房X光检查
      • 泌尿外科和肾脏病学
    • 按最终用途
      • 医院
      • 诊断中心
      • 日间手术中心 (ASC)
      • 其他（学术研究中心）
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美医学图像分析软件市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
    • 按方式
    • 通过成像
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 我们
      • 加拿大

第6章欧洲医学图像分析软件市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
    • 按方式
    • 通过成像
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太医学图像分析软件市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
    • 按方式
    • 通过成像
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第8章拉丁美洲医学图像分析软件市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
    • 按方式
    • 通过成像
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲医学图像分析软件市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 通过软件
    • 按方式
    • 通过成像
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 主要公司及其产品列表
  • 图：2022年全球医学图像分析软件企业市场份额分析
  • 通过管理参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球医学图像分析软件市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Toshiba Medical Systems Corp.
  • Bruker Corp.
  • Xinapse Systems Ltd.
  • Esaote, Inc.
  • ClaroNAv, Inc.
  • Merge Healthcare Inc.
  • Aquilab GmbH
  • Spacelabs Healthcare, Inc.
  • MIM Software Inc.
  • Carestream Health, Inc.
  • Agfa-Gevaert Corp.
  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和数据三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者的地区分布
  • 假设和限制
简介目录
Product Code: BWC23522

Global Medical Image Analysis Software Market Size Set to Cross USD 5.62 Billion by 2029

Global medical image analysis software market is flourishing due to the increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, and the growing adoption of technologically advanced medical image equipment, such as multimodality imaging platforms and 3D imaging.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global medical image analysis software market size at USD 3.30 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global medical image analysis software market size to grow at a CAGR of 7.80% reaching a value of USD 5.62 billion by 2029. The increasing use of ultrasonic imaging equipment for faster diagnosis, particularly of persistent illnesses, is likely to drive the demand for medical image analysis software. The increasing adoption of technologically advanced products, such as multimodality imaging platforms and 3D imaging, as well as the benefits of using these systems, such as high-resolution imaging, ease of use, and flexibility, is driving rising consumer demand. The growing elderly population has increased the number of chronic diseases. The rising prevalence of such disorders may increase the use of diagnostic imaging technologies, enhancing the market for medical imaging analysis software.

Opportunity: Introduction of CT-guided diagnosis

Radiation exposure for patients and medical staff has gradually increased with the advent of CT-guided diagnosis and intervention, including nuclear medicine-based scans and angiography. As a result, statutory organizations have made it essential for patients' radiation exposure to be monitored and reported in their medical records. It is also crucial to monitor how much radiation doctors are exposed to while performing their duties. For instance, DoseWatch is a program offered by GE to keep track of the radiation doses supplied to patients at a certain facility. Data can be categorized according to devices, protocols, or operators to make it easier to find dose outliers. Sectra provides web-based dose tracking. Sectra is attributed by the American College of Radiology and may transmit dosage data directly from a hospital to its Dose Index Registry. Therefore, the increasing number of the introduction of CT-guided diagnosis is expected to create lucrative opportunities for the growth of the global medical image analysis software market in the coming years.

Restraint: Budgetary constraints

The global medical image analysis software market is projected to encounter budgetary constraints, due to a variety of factors, including limited funding for healthcare R&D, the high cost of developing and maintaining these software solutions, and by healthcare providers and organizations. The high cost of developing and sustaining these solutions is one of the major constraints for medical image analysis software suppliers. The development of these software solutions requires significant R&D investment, including the expense of employing trained individuals, developing and testing algorithms, and gathering high-quality imaging data. The ongoing maintenance and support of these software solutions can be expensive. These factors may hamper market growth in the coming years.

Impact of COVID-19 on Global Medical Image Analysis Software Market

The global medical image analysis software market was significantly impacted by the COVID-19 pandemic. Considering the importance of medical imaging in diagnosing and treating severe COVID-19 infections, the medical imaging sector witnessed considerable growth during the COVID-19 pandemic. Medical imaging software methods are also used in the care of COVID-19 patients. Chest X-rays, CT scans, and ultrasonography were commonly used to identify the extent of COVID-19 infections and the disease's progress in the lungs. All of these factors led to a rise in global market demand. Thus, the COVID-19 pandemic positively impacted the global medical image analysis software market growth.

Global Medical Image Analysis Software Market - By Application:

Based on application, the global medical image analysis software market is divided into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, mammography, and urology & nephrology segments. Neurology is expected to be the fastest-growing application segment during the forecast period, due to a rising incidence of brain cancer, tumors, and other brain-related ailments, which is expected to drive the market growth for medical image analysis software over the forecast period. The increased emphasis on the most recent technological advances in the medical industry has a significant impact on the market expansion.

Global Medical Image Analysis Software Market - By End User:

Based on end user, the global medical image analysis software market is segmented into hospitals, diagnostic centers, ambulatory surgical centers (ASCS), and others (academic & research centers). The hospitals segment dominated the market and accounted for a significant market share. Supportive infrastructure, which is essential in performing surgical interventions using medical imaging software, is one of the important reasons for supporting the segment's expansion. Hospitals have a larger installed base of diagnostic imaging systems and solutions than research and diagnostic centers. Patient inflow is significantly higher. It keeps the end-use portion in the first place.

Global Medical Image Analysis Software Market - By Region:

Asia Pacific is expected to grow significantly in the global medical image analysis software market during the period in analysis. Rising investments in healthcare, improved healthcare infrastructure, and increasing adoption of medical imaging devices, AI, and telehealth services are expected to drive the growth of this regional market. Economic development in APAC has greatly boosted access to healthcare and improved healthcare infrastructure. The region's healthcare sector is expected to undergo significant change over the next five years.

Competitive Landscape:

The global medical image analysis software market is highly competitive, with all the players continually competing to gain a larger market share. Key players in the market include Toshiba Medical Systems Corp., Bruker Corp., Xinapse Systems Ltd., Esaote, Inc., ClaroNAv, Inc., Merge Healthcare Inc., Aquilab GmbH, Spacelabs Healthcare, Inc., MIM Software Inc., Carestream Health, Inc., Agfa-Gevaert Corp., Philips Healthcare, Siemens Healthineers, and GE Healthcare.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global Medical Image Analysis Software Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global Global Medical image analysis software Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Image Analysis Software Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Incorporation of AI in Medical Image Analysis Software
      • 3.2.1.3. Rising Need for Efficiency and Effectiveness
    • 3.2.2. Restraints
      • 3.2.2.1. Budgetary Constraints
      • 3.2.2.2. Increasing Concern Regarding the Compliance and Security of Software
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancement in technology
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of Skilled Professionals
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Image Analysis Software Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Software
      • 4.2.1.1. Integrated Software
      • 4.2.1.2. Stand-alone Software
    • 4.2.2. By Modality
      • 4.2.2.1. Tomography
      • 4.2.2.1.1. Computed Tomography
      • 4.2.2.1.2. Magnetic Resonance Imaging
      • 4.2.2.1.3. Positron Emission Tomography
      • 4.2.2.1.4. Single-Photon Emission Tomography
      • 4.2.2.2. Ultrasound Imaging
      • 4.2.2.3. Radiographic Imaging
      • 4.2.2.4. Combined Modalities
    • 4.2.3. By Imaging
      • 4.2.3.1. 2D Imaging
      • 4.2.3.2. 3D Imaging
      • 4.2.3.3. 4D Imaging
    • 4.2.4. By Application
      • 4.2.4.1. Orthopedic
      • 4.2.4.2. Dental
      • 4.2.4.3. Neurology
      • 4.2.4.4. Cardiology
      • 4.2.4.5. Oncology
      • 4.2.4.6. Obstetrics & Gynecology
      • 4.2.4.7. Mammography
      • 4.2.4.8. Urology & Nephrology
    • 4.2.5. By End Use
      • 4.2.5.1. Hospitals
      • 4.2.5.2. Diagnostic Centers
      • 4.2.5.3. Ambulatory Surgical Centers (ASCs)
      • 4.2.5.4. Others (Academic & Research Centers)
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific (APAC)
      • 4.2.6.4. Latin America (LATAM)
      • 4.2.6.5. Middle East and Africa (MEA)

5. North America Medical Image Analysis Software Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Software
    • 5.2.2. By Modality
    • 5.2.3. By Imaging
    • 5.2.4. By Application
    • 5.2.5. By End User
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Software
      • 5.2.6.1.2. By Modality
      • 5.2.6.1.3. By Imaging
      • 5.2.6.1.4. By Application
      • 5.2.6.1.5. By End User
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Software
      • 5.2.6.2.2. By Modality
      • 5.2.6.2.3. By Imaging
      • 5.2.6.2.4. By Application
      • 5.2.6.2.5. By End User

6. Europe Medical Image Analysis Software Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Software
    • 6.2.2. By Modality
    • 6.2.3. By Imaging
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Software
      • 6.2.6.1.2. By Modality
      • 6.2.6.1.3. By Imaging
      • 6.2.6.1.4. By Application
      • 6.2.6.1.5. By End User
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Software
      • 6.2.6.2.2. By Modality
      • 6.2.6.2.3. By Imaging
      • 6.2.6.2.4. By Application
      • 6.2.6.2.5. By End User
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Software
      • 6.2.6.3.2. By Modality
      • 6.2.6.3.3. By Imaging
      • 6.2.6.3.4. By Application
      • 6.2.6.3.5. By End User
      • 6.2.6.4. France
      • 6.2.6.4.1. By Software
      • 6.2.6.4.2. By Modality
      • 6.2.6.4.3. By Imaging
      • 6.2.6.4.4. By Application
      • 6.2.6.4.5. By End User
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Software
      • 6.2.6.5.2. By Modality
      • 6.2.6.5.3. By Imaging
      • 6.2.6.5.4. By Application
      • 6.2.6.5.5. By End User
      • 6.2.6.6. Belgium
      • 6.2.6.6.1. By Software
      • 6.2.6.6.2. By Modality
      • 6.2.6.6.3. By Imaging
      • 6.2.6.6.4. By Application
      • 6.2.6.6.5. By End User
      • 6.2.6.7. Russia
      • 6.2.6.7.1. By Software
      • 6.2.6.7.2. By Modality
      • 6.2.6.7.3. By Imaging
      • 6.2.6.7.4. By Application
      • 6.2.6.7.5. By End User
      • 6.2.6.8. The Netherlands
      • 6.2.6.8.1. By Software
      • 6.2.6.8.2. By Modality
      • 6.2.6.8.3. By Imaging
      • 6.2.6.8.4. By Application
      • 6.2.6.8.5. By End User
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Software
      • 6.2.6.9.2. By Modality
      • 6.2.6.9.3. By Imaging
      • 6.2.6.9.4. By Application
      • 6.2.6.9.5. By End User

7. Asia-Pacific Medical Image Analysis Software Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Software
    • 7.2.2. By Modality
    • 7.2.3. By Imaging
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Software
      • 7.2.6.1.2. By Modality
      • 7.2.6.1.3. By Imaging
      • 7.2.6.1.4. By Application
      • 7.2.6.1.5. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Software
      • 7.2.6.2.2. By Modality
      • 7.2.6.2.3. By Imaging
      • 7.2.6.2.4. By Application
      • 7.2.6.2.5. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Software
      • 7.2.6.3.2. By Modality
      • 7.2.6.3.3. By Imaging
      • 7.2.6.3.4. By Application
      • 7.2.6.3.5. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Software
      • 7.2.6.4.2. By Modality
      • 7.2.6.4.3. By Imaging
      • 7.2.6.4.4. By Application
      • 7.2.6.4.5. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Software
      • 7.2.6.5.2. By Modality
      • 7.2.6.5.3. By Imaging
      • 7.2.6.5.4. By Application
      • 7.2.6.5.5. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Software
      • 7.2.6.6.2. By Modality
      • 7.2.6.6.3. By Imaging
      • 7.2.6.6.4. By Application
      • 7.2.6.6.5. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Software
      • 7.2.6.7.2. By Modality
      • 7.2.6.7.3. By Imaging
      • 7.2.6.7.4. By Application
      • 7.2.6.7.5. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Software
      • 7.2.6.8.2. By Modality
      • 7.2.6.8.3. By Imaging
      • 7.2.6.8.4. By Application
      • 7.2.6.8.5. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Software
      • 7.2.6.9.2. By Modality
      • 7.2.6.9.3. By Imaging
      • 7.2.6.9.4. By Application
      • 7.2.6.9.5. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Software
      • 7.2.6.10.2. By Modality
      • 7.2.6.10.3. By Imaging
      • 7.2.6.10.4. By Application
      • 7.2.6.10.5. By End User

8. Latin America Medical Image Analysis Software Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Software
    • 8.2.2. By Modality
    • 8.2.3. By Imaging
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Software
      • 8.2.6.1.2. By Modality
      • 8.2.6.1.3. By Imaging
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Software
      • 8.2.6.2.2. By Modality
      • 8.2.6.2.3. By Imaging
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Software
      • 8.2.6.3.2. By Modality
      • 8.2.6.3.3. By Imaging
      • 8.2.6.3.4. By Application
      • 8.2.6.3.5. By End User
      • 8.2.6.4. Peru
      • 8.2.6.4.1. By Software
      • 8.2.6.4.2. By Modality
      • 8.2.6.4.3. By Imaging
      • 8.2.6.4.4. By Application
      • 8.2.6.4.5. By End User
      • 8.2.6.5. Rest of LATAM
      • 8.2.6.5.1. By Software
      • 8.2.6.5.2. By Modality
      • 8.2.6.5.3. By Imaging
      • 8.2.6.5.4. By Application
      • 8.2.6.5.5. By End User

9. Middle East & Africa Medical Image Analysis Software Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Software
    • 9.2.2. By Modality
    • 9.2.3. By Imaging
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Software
      • 9.2.6.1.2. By Modality
      • 9.2.6.1.3. By Imaging
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Software
      • 9.2.6.2.2. By Modality
      • 9.2.6.2.3. By Imaging
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Qatar
      • 9.2.6.3.1. By Software
      • 9.2.6.3.2. By Modality
      • 9.2.6.3.3. By Imaging
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. Kuwait
      • 9.2.6.4.1. By Software
      • 9.2.6.4.2. By Modality
      • 9.2.6.4.3. By Imaging
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. South Africa
      • 9.2.6.5.1. By Software
      • 9.2.6.5.2. By Modality
      • 9.2.6.5.3. By Imaging
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Software
      • 9.2.6.6.2. By Modality
      • 9.2.6.6.3. By Imaging
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Algeria
      • 9.2.6.7.1. By Software
      • 9.2.6.7.2. By Modality
      • 9.2.6.7.3. By Imaging
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. Rest of MEA
      • 9.2.6.8.1. By Software
      • 9.2.6.8.2. By Modality
      • 9.2.6.8.3. By Imaging
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Medical Image Analysis Software Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Image Analysis Software Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Toshiba Medical Systems Corp.
  • 12.2. Bruker Corp.
  • 12.3. Xinapse Systems Ltd.
  • 12.4. Esaote, Inc.
  • 12.5. ClaroNAv, Inc.
  • 12.6. Merge Healthcare Inc.
  • 12.7. Aquilab GmbH
  • 12.8. Spacelabs Healthcare, Inc.
  • 12.9. MIM Software Inc.
  • 12.10. Carestream Health, Inc.
  • 12.11. Agfa-Gevaert Corp.
  • 12.12. Philips Healthcare
  • 12.13. Siemens Healthineers
  • 12.14. GE Healthcare
  • 12.15. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations